Dorato Capital Management Takes Position in Cardinal Health, Inc. $CAH

Dorato Capital Management bought a new stake in Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 3,589 shares of the company’s stock, valued at approximately $766,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Integrated Wealth Concepts LLC boosted its stake in shares of Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after buying an additional 280 shares during the period. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in shares of Cardinal Health by 7.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 13,355 shares of the company’s stock worth $2,244,000 after buying an additional 869 shares during the period. Mackenzie Financial Corp raised its holdings in Cardinal Health by 9.9% in the second quarter. Mackenzie Financial Corp now owns 29,023 shares of the company’s stock valued at $4,876,000 after acquiring an additional 2,616 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new position in Cardinal Health in the second quarter worth approximately $1,935,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.9%

CAH stock opened at $214.00 on Friday. The stock has a market cap of $50.36 billion, a P/E ratio of 30.79, a PEG ratio of 1.37 and a beta of 0.64. Cardinal Health, Inc. has a twelve month low of $120.72 and a twelve month high of $233.60. The company’s 50 day moving average is $217.52 and its two-hundred day moving average is $197.78.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The business had revenue of $65.63 billion during the quarter, compared to analysts’ expectations of $64.88 billion. During the same quarter in the prior year, the business posted $1.93 EPS. The company’s revenue for the quarter was up 18.8% on a year-over-year basis. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 29.35%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, January 21st. Morgan Stanley set a $255.00 price objective on shares of Cardinal Health in a research report on Friday, February 6th. Jefferies Financial Group boosted their target price on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, January 22nd. Wells Fargo & Company increased their target price on Cardinal Health from $237.00 to $256.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Finally, Leerink Partners restated an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $245.67.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.